-0.09 (-3.191%)
ASX:Live
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Weak
Halo Model
MQV
Weak
GARP
Weak
MQV Small
Very Weak
Valuation
Value
Consensus
Momentum
Price
Very Strong
Earnings
Very Weak
Growth
Earnings
Weak
Dividends
Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Strong
Website
N/A
Telephone
61.13.0045.3688
Address
1868-1892 Dandenong Road Clayton, Victoria (VIC) 3168
Description
Australian Clinical Labs Ltd. engages in the provision of pathology services. It operates through the Pathology segment. The Pathology segment includes pathology/clinical laboratory services provided in Australia. The company was founded in 2015 and is headquartered in Clayton, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 2.32 - 3.86
Trade Value (12mth)
AU$1,017,548.00
1 week
-1.8%
1 month
-12.5%
YTD
-20.18%
1 year
10.98%
All time high
6.39
EPS 3 yr Growth
-69.70%
EBITDA Margin
26.90%
Operating Cashflow
$160m
Free Cash Flow Return
41.50%
ROIC
6.20%
Interest Coverage
10.90
Quick Ratio
0.60
Shares on Issue (Fully Dilluted)
202m
HALO Sector
Healthcare
Next Company Report Date
20-Aug-25
Ex Dividend Date (est.)
27-Mar-25
Next Dividend Pay Date (est.)
16-Apr-25
Reporting Currency
AUD
Short Sell (% of issue)
2.16
| Date | Announcements |
|---|---|
|
11 June 25 |
Change in substantial holding
×
Change in substantial holding |
|
11 June 25 |
Change in substantial holding
×
Change in substantial holding |
|
05 June 25 |
Change in substantial holding
×
Change in substantial holding |
|
03 June 25 |
Change in substantial holding
×
Change in substantial holding |
|
30 May 25 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
29 May 25 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
27 May 25 |
Notification of cessation of securities - ACL
×
Notification of cessation of securities - ACL |
|
26 May 25 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
23 May 25 |
Notification of cessation of securities - ACL
×
Notification of cessation of securities - ACL |
|
20 May 25 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
16 May 25 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
15 May 25 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
14 May 25 |
Change in substantial holding
×
Change in substantial holding |
|
09 May 25 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
09 May 25 |
Change in substantial holding
×
Change in substantial holding |
|
08 May 25 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
08 May 25 |
Notification of cessation of securities - ACL
×
Notification of cessation of securities - ACL |
|
05 May 25 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
02 May 25 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
01 May 25 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
30 April 25 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
30 April 25 |
Final Director's Interest Notice - M Alscher
×
Final Director's Interest Notice - M Alscher |
|
30 April 25 |
Notification of cessation of securities - ACL
×
Notification of cessation of securities - ACL |
|
29 April 25 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
28 April 25 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
Load More
Load Less
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
.svg)
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.
